The morphologies of BT-474 cells preincubated with ( A ) Culture... | Download Scientific Diagram
A. The effect of trastuzumab on the viability of the BT-474 (parental,... | Download Scientific Diagram
Conditioned media from MCF7 and BT474 breast cancer cells induce insulin resistance in skeletal muscle myotubes | bioRxiv
Growth of BT-474 cells incubated with the conditioned media of MCF-10A... | Download Scientific Diagram
C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells | BMC Cancer | Full Text
Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation | PLOS ONE
Human Breast Carcinoma, ductal cell line BT-474-BHC11100222
BT-474 - HTB-20 | ATCC
BT-474 Clone 5 - CRL-3247 | ATCC
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients | PNAS
6. Arthur carried out a study to examine the effect | Chegg.com
Conditioned media from MCF7 and BT474 breast cancer cells induce insulin resistance in skeletal muscle myotubes. Mona S. Alia, X
BT-474 Tam2 - CRL-3434 | ATCC
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment | PLOS ONE
PTEN suppresses epithelial–mesenchymal transition and cancer stem cell activity by downregulating Abi1 | Scientific Reports
Cancers | Free Full-Text | MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation | Nature Communications
Human Breast Carcinoma, ductal cell line BT-474-BHC11100222
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles | PNAS
